Trump Administration Halts Medicaid Funding For Transgender Youth Care

Trump Administration Announces Medicaid Funding Halt for Transgender Youth Care

Mr. Trump stated in a social media post that he directed Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz to make the change. We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies, Mr. Trump said. CMS Administrator Mehmet Oz defended the move by stating that federal Medicaid funds should not be used for gender-transition surgeries or hormone treatments involving minors.

Details of the New Federal Policy and Phased Coverage

Under the policy, Medicaid and CHIP will continue to cover mental health treatment for transgender minors. However, the policy calls for phasing out coverage of hormone treatments—which are utilized both to block puberty and to produce sex-related physical changes—for individuals already receiving them as of April 2027.

The exact amount of taxpayer funding currently covering gender-affirming treatments for transgender youth remains unclear, and the Centers for Medicare and Medicaid Services did not respond to questions regarding the policy.

Wider Context of Restrictions and Medical Landscape

The announcement follows a series of administration policies regarding transgender individuals that began after Mr. Trump returned to office. Prior actions include cutting off Medicaid and Medicare funding for hospitals providing gender-affirming care to minors, barring transgender athletes from girls’ and women’s sports competitions, and blocking individuals from selecting male, female, or X sex designations on passports. Most of these changes have encountered legal challenges, with the U.S. Supreme Court allowing the passport policy and state sports bans to stand, while a challenge regarding hospitals remains pending.

Obamacare Enrollment Drops by 1.2M: Trump Blames Fraud, States & Insurers Cite Skyrocketing Premiums

Nationwide, at least 27 states have banned gender-affirming care for individuals under 18. While major medical organizations like the American Medical Association support access to gender-affirming care, the American Society of Plastic Surgeons stated that it found insufficient evidence that the benefits of chest, facial, and genital surgeries for minors with gender dysphoria outweigh the risks. Gender-affirming surgeries for minors are rare, whereas puberty blockers and hormone treatments are more common.

Reactions From Advocacy Groups

Advocates for LGBTQ+ young people sharply criticized the directive. Josh Rovenger, legal director for GLBTQ Legal Advocates and Defenders, stated that the rule is putting up barriers between parents and their ability to make the best medical decisions for their children and announced it would face a legal challenge. Human Rights Campaign President Kelley Robinson stated in a release that The Trump administration is terrorizing trans youth and their families with these kinds of actions, and it has to stop, noting that the HRC is already suing the administration over efforts to bar gender-affirming care coverage in federal employee benefit plans.